PeptideStack
5.2kquestions
20kanswers
220users

Is hair thinning on a GLP-1 receptor agonist dose-dependent or dose-rate dependent?

Asked 10 Jan 2025Modified 15 months agoViewed 18k times
13

Setup, so nobody has to ask: hair thinning · a GLP-1 receptor agonist.

I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.

My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.

Why does this happen, and what would falsify the usual explanation?

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
shareeditfollowflag
AD
askedanouk_desmet16k3810 Jan 2025

5 Answers

Accepted answer first, then by votes
-3

Accepted answer

Start with the timing, because telogen effluvium has a characteristic delay of two to four months between the trigger and the shed.

The trigger in this context is the rate of weight loss and the associated nutritional deficit, not a pharmacological property. The same phenomenon is well documented after bariatric surgery, illness and childbirth.

Gastrointestinal adverse events, indicative pooled rates

EventActive armPlacebo armTiming
Nausea40–45 %15–20 %Peaks 1–2 wk after each step
Vomiting15–25 %5–8 %Follows nausea
Diarrhoea20–30 %10–15 %Early, variable
Constipation20–25 %8–12 %Later onset, persistent
Discontinuation for GI events4–7 %1–2 %Mostly during escalation

Ranges span agents and doses; read the specific prescribing information for a specific figure.

Specifically, nothing topical has strong evidence for accelerating recovery from telogen effluvium specifically, as distinct from androgenetic loss where the evidence is entirely different.

The two-to-four-month latency follows directly from the duration of the telogen phase and is the diagnostic feature of the condition.

Check ferritin, thyroid and vitamin D once, then stop investigating.

shareimprove this answerflag
NA
answered · acceptednoor_alhassan11k2728 Feb 2025
2The red-flag list should be higher up the answer, not at the bottom. – laminar_bench 7 months ago
3Worth adding that the area postrema explanation also predicts why it settles. – marta_szymanska 8 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
12

The honest answer is that it resolves in most cases within six to nine months and that the resolution cannot be hurried much.

Adequate protein matters. Hair is largely keratin, and follicles are among the most metabolically active tissues, so they are early casualties of a substantial protein shortfall.

It is diffuse: increased shedding across the whole scalp, often noticed in the shower or on a brush, without a receding hairline or a defined crown pattern. Patterned loss is androgenetic and unrelated.

It resolves in most cases over six to twelve months. That is genuinely the answer.

shareimprove this answerflag
RP
answeredrhian_prydderch23k2712 Mar 2025
8I would add a sentence about when to stop managing it and start seeing someone. – Dr_Yusuf_Adeyemi 3 months ago
add a comment
12

The short version: diffuse rather than patterned, delayed rather than immediate, self-limiting, and driven by the rate of loss rather than by the compound.

Worth checking: ferritin, thyroid function and vitamin D. Low ferritin in particular is associated with shedding at levels that are not low enough to cause anaemia.

Specifically, in telogen effluvium a stressor shifts a large fraction of follicles from anagen into telogen simultaneously. Because telogen lasts around two to three months, the shed appears two to four months after the trigger rather than during it.

Low ferritin is associated with increased shedding in observational studies at thresholds above those used to define anaemia.

The trigger is the rate of loss, not the compound. Slowing it helps future follicles.

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi104k24723 Mar 2025
9

Mechanically, this is one of the most distressing reported effects and one of the most reliably temporary.

Recovery follows the same timeline in reverse: shedding stops within a few months of the trigger resolving, and visible density returns over six to twelve months as regrowth reaches length.

Diffuse and delayed means telogen effluvium. Patterned means something else.

edited 3 May 2025 by rhian_prydderch — reworded for clarity after a comment

shareimprove this answerflag
RP
answeredrhian_prydderch23k273 Apr 2025
4

Answering this needs the rate of weight loss and the protein intake, since those are the two modifiable contributors.

Slowing the rate of weight loss reduces the severity of the trigger. It does not reverse a shed already in progress, because the follicles have already committed.

Protein intake is the modifiable nutritional factor worth attending to.

shareimprove this answerflag
NT
answeredn_takahashi29k3814 Apr 2025
4The distinction between escalation-related and steady-state is the useful part. – ines_brandt 8 months ago
5I have seen this misattributed to the compound twice when it was the deficit. – pierce_count 10 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.